IL-17A刺激的miR-214调控强直性脊柱炎骨丢失
该研究纳入32例AS患者和24例健康对照,检测血清IL-17A、RANKL、骨保护素及miR-214水平,并在小鼠成骨细胞和骨髓细胞中评估miR-214、IL-17A与骨丢失的关系。结果显示IL-17A刺激成骨细胞产生miR-214,后者可转移至破骨细胞并调控其活性,AS患者血清IL-17A和miR-214水平升高且正相关,miR-214可能具有诊断价值。
要点
- IL-17A刺激成骨细胞产生miR-214,miR-214可转移至破骨细胞并调控其活性。
- AS患者血清IL-17A和miR-214水平高于健康对照,且两者正相关。
- 血清miR-214水平对AS可能具有潜在诊断价值。
核心结论
- IL-17A刺激成骨细胞产生miR-214,miR-214是AS骨形成的重要抑制剂,血清miR-214水平可能对AS具有潜在诊断价值。
研究设计与样本
- 研究纳入32例AS患者和24例健康对照,采集外周血,用ELISA检测血清IL-17A、可溶性RANKL和骨保护素水平,用实时定量PCR检测血清miR-214相对水平。
- 在小鼠原代成骨细胞和骨髓细胞中评估miR-214、IL-17A水平与骨丢失的关系。
主要发现
- IL-17A刺激后成骨细胞中RANKL和miR-214表达增加,且IL-17A刺激的成骨细胞促进破骨细胞中miR-214表达和破骨细胞活性。
- 成骨细胞来源的miR-214可转移至破骨细胞并调控其活性。
- AS患者血清IL-17A和miR-214水平高于健康对照,且AS患者血清和滑液中miR-214相对水平与IL-17A水平正相关,健康对照中无此相关性。
临床怎么用
- 血清miR-214水平可能作为AS的潜在诊断标志物,但需进一步验证。
- IL-17A-miR-214轴可能为AS骨丢失的干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Bone loss is common in AS, and miR-214 plays an important role in regulating bone formation. The aim of this study was to investigate the effect of miR-214, the production of which is stimulated by IL-17A, on bone loss in AS. METHODS: Peripheral blood was obtained from 32 patients with AS and 24 healthy controls. Levels of IL-17A, soluble RANK ligand (RANKL) and osteoprotegerin in serum were evaluated by ELISA, and the relative level of miR-214 in serum was detected by real-time quantitative PCR. In addition, we assessed the relationship between levels of miR-214, IL-17A and bone loss in primary murine osteoblasts and mouse bone marrow cells. RESULTS: The expression of RANKL and miR-214 in osteoblasts was increased following stimulation by IL-17A, and osteoblasts stimulated by IL-17A promoted the expression of miR-214 in osteoclasts and the activity of osteoclasts. We showed that osteoblast-derived miR-214 could be transferred to osteoclasts and could then regulate their activity. The levels of IL-17A and miR-214 were much higher in the serum of patients with AS than in that of healthy controls, and the relative level of miR-214 was positively correlated with the level of IL-17A in the serum and synovial fluid of the patients with AS, not healthy controls. The level of miR-214 in the serum of AS patients has potential diagnostic value. CONCLUSION: The production of miR-214 in osteoblasts is stimulated by IL-17A. It is an important inhibitor of bone formation in AS, and the serum level of miR-214 might be of potential diagnostic value for AS.
引用
- Liu Z, Huang F, Luo G, et al. miR-214 stimulated by IL-17A regulates bone loss in patients with ankylosing spondylitis. Rheumatology (Oxford). 2020. PMID: 31846044. doi:10.1093/rheumatology/kez594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。